The cell line is not submitted yet.
(only basic data is shown)
General
Cell Line |
|
| hPSCreg name | SCTi005-A |
| Cite as: | SCTi005-A |
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines | No similar lines found. |
| Last update | 25th March 2025 |
| Notes | Healthy Control Human iPSC Line, Female, SCTi005-A was derived from peripheral blood mononuclear cells (PBMCs) from a 28-year-old donor. Extensive quality control procedures were undertaken in the induced pluripotent stem cell (iPSC) manufacturing process to ensure optimal product performance and reproducibility. SCTi005-A is karyotypically stable, demonstrates trilineage differentiation potential, expresses markers of the undifferentiated state, and was reprogrammed using Sendai virus. SCTi005-A is manufactured with mTeSR™ Plus (Catalog #100-0276) and may be used as a healthy control for a multitude of pluripotent stem cell research applications, including downstream differentiation to lineage-specific cell types and organoids. |
| User feedback | |
Provider |
|
| Generator |
STEMCELL Technologies Inc. (SCT)
Contact:
STEMCELL Technologies Inc. (SCT) |
| Owner | STEMCELL Technologies Inc. (SCT) |
| Distributors | |
External Databases |
|
| BioSamples | SAMEA116997700 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: allowed
Additional restrictions:
For in vitro research use only. Not approved for diagnostic, therapeutic, or clinical applications. Not approved for human or veterinary use in vivo. |
hIPSC Derivation
General |
Login to share your feedback, experiences or results with the research community.